Central Pontine Myelinolysis in a Normonatremic Patient with Depression
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
A 76-year-old male presented with a recurrent depressive episode, an unsteady gait and cognitive impairment. Extensive blood tests, including hemogram, biochemical tests, folic acid, vitamin B12, and thyroid hormone, showed normal results. With the exception of the unsteady gait, neurological examination was negative. Brian magnetic resonance imaging (MRI) showed the typical feature of central pontine myelinolysis (CPM); however, there was no history of alcoholism, liver transplantation, malnutrition or rapid correction of hyponatremia. The patient had taken venlafaxine to treat major depressive disorder for more than 20 years. After discontinuation of venlafaxine, the unsteady gait gradually resolved, and subsequent MRI revealed reduction of the lesions over 6 months. We discuss herein the possible correlation between chronic use of venlafaxine and CPM.
Abstract
A 76-year-old male presented with a recurrent depressive episode, an unsteady gait and cognitive impairment. Extensive blood tests, including hemogram, biochemical tests, folic acid, vitamin B12, and thyroid hormone, showed normal results. With the exception of the unsteady gait, neurological examination was negative. Brian magnetic resonance imaging (MRI) showed the typical feature of central pontine myelinolysis (CPM); however, there was no history of alcoholism, liver transplantation, malnutrition or rapid correction of hyponatremia. The patient had taken venlafaxine to treat major depressive disorder for more than 20 years. After discontinuation of venlafaxine, the unsteady gait gradually resolved, and subsequent MRI revealed reduction of the lesions over 6 months. We discuss herein the possible correlation between chronic use of venlafaxine and CPM.
참고문헌 (11)
- Lampl C, "Central pontine myelinolysis", Eur Neurol, 47, pp.3~10 (2002)
- Ashrafian H, "A review of the causes of central pontine myelinosis: yet another apoptotic illness?", Eur J Neurol, 8, pp.103~109 (2001)
- Martin RJ, "Central pontine and extrapontine myelinolysis : the osmotic demyelination syndromes", J Neurol Neurosurg Psychiatry, 75(Suppl 3), pp.iii22~iii28 (2004)
- Liu J, "Exploration of major cognitive deficits in medication-free patients with major depressive disorder", Front Psychiatry, 10, pp.836~ (2019)
- Bose P, "Central pontine myelinolysis without hyponatraemia", J R Coll Physicians Edinb, 41, pp.211~214 (2011)
- Kilinç M, "Osmotic myelinolysis in a normonatremic patient", Acta Neurol Belg, 102, pp.87~89 (2002)
- Min-Jee Han, "A Case of Osmotic Demyelination Presenting with Severe Hypernatremia", Electrolytes & Blood Pressure, 13(1), pp.30~36 (2015), 전해질고혈압연구회[DOI]
- Shah MK, "Osmotic demyelination unrelated to hyponatremia", Am J Kidney Dis, 71, pp.436~440 (2018)
- De Picker L, "Antidepressants and the risk of hyponatremia : a class-byclass review of literature", Psychosomatics, 55, pp.536~547 (2014)
- Twardowschy CA, "Pontine and extrapontine osmotic myelinolysis after the syndrome of inappropriate secretion of antidiuretic hormone(SIADH)associated with fluoxetine : case report", Arq Neuropsiquiatr, 65, pp.858~864 (2007)
- Lupato A, "A case of asymptomatic pontine myelinolysis", Neurol Sci, 31, pp.361~364 (2010)